Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)

MC Heinrich; RL Jones; M von Mehren; P Schöffski; C Serrano; YK Kang; PA Cassier; O Mir; F Eskens; WD Tap; P Rutkowski; SP Chawla; J Trent; M Tugnait; EK Evans; T Lauz; T Zhou; M Roche; BB Wolf; S Bauer; S George

Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)

MC Heinrich
, RL Jones
, M von Mehren
, P Schöffski
, C Serrano
, YK Kang
, PA Cassier
, O Mir
, F Eskens
, WD Tap
, P Rutkowski
, SP Chawla
, J Trent
, M Tugnait
, EK Evans
, T Lauz
, T Zhou
, M Roche
, BB Wolf
, S Bauer

S George

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	E418-E418
Number of pages	1
Journal	Lancet Oncology
Volume	21
Issue number	9
State	Published - Sep 2020

Cite this

Heinrich, MC., Jones, RL., von Mehren, M., Schöffski, P., Serrano, C., Kang, YK., Cassier, PA., Mir, O., Eskens, F., Tap, WD., Rutkowski, P., Chawla, SP., Trent, J., Tugnait, M., Evans, EK., Lauz, T., Zhou, T., Roche, M., Wolf, BB., ... George, S. (2020). Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020). Lancet Oncology, 21(9), E418-E418.

@article{edbc46a6ba174a99b313af21af25598c,

title = "Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)",

author = "MC Heinrich and RL Jones and \{von Mehren\}, M and P Sch{\"o}ffski and C Serrano and YK Kang and PA Cassier and O Mir and F Eskens and WD Tap and P Rutkowski and SP Chawla and J Trent and M Tugnait and EK Evans and T Lauz and T Zhou and M Roche and BB Wolf and S Bauer and S George",

year = "2020",

month = sep,

language = "American English",

volume = "21",

pages = "E418--E418",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "9",

}

Heinrich, MC, Jones, RL , von Mehren, M, Schöffski, P, Serrano, C, Kang, YK, Cassier, PA, Mir, O, Eskens, F, Tap, WD, Rutkowski, P, Chawla, SP, Trent, J, Tugnait, M, Evans, EK, Lauz, T, Zhou, T, Roche, M, Wolf, BB, Bauer, S & George, S 2020, 'Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)', Lancet Oncology, vol. 21, no. 9, pp. E418-E418.

TY - JOUR

T1 - Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR)

T2 - a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)

AU - Heinrich, MC

AU - Jones, RL

AU - von Mehren, M

AU - Schöffski, P

AU - Serrano, C

AU - Kang, YK

AU - Cassier, PA

AU - Mir, O

AU - Eskens, F

AU - Tap, WD

AU - Rutkowski, P

AU - Chawla, SP

AU - Trent, J

AU - Tugnait, M

AU - Evans, EK

AU - Lauz, T

AU - Zhou, T

AU - Roche, M

AU - Wolf, BB

AU - Bauer, S

AU - George, S

PY - 2020/9

Y1 - 2020/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000568490900044&DestLinkType=FullRecord&DestApp=WOS

M3 - Article

SN - 1470-2045

VL - 21

SP - E418-E418

JO - Lancet Oncology

JF - Lancet Oncology

IS - 9

ER -

Correction: Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial (vol 21, pg 935, 2020)

Other files and links

Fingerprint

Cite this